Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Non-Randomized, Open-Label, Multi-Center, Single Arm Study of Exchange of Travoprost Intraocular Implant

NCT04615403 is registered in ClinicalTrials.gov with Glaukos Corporation as lead sponsor.

NCT NCT04615403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04615403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Non-Randomized, Open-Label, Multi-Center, Single Arm Study of Exchange of Travoprost Intraocular Implant
Lead sponsor
Glaukos Corporation
Phase
Phase 2
Overall status
Completed
Start date
November 19, 2020
Completion date
February 28, 2022
Enrollment
33 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

open angle glaucoma